Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Tobramycin.

Menu
$ API Ref.Price (USD/KG) : 2,226Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Alcon Canada Inc.

02 2BGP Pharma ULC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Tobramycin

Brand Name : TOBRAMYCIN

Patent Number : 2414737

Filing Date : 2001-06-26

Strength per Unit : 0.3%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2021-06-26

Date Granted : 2009-01-06

blank

02

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Tobramycin

Brand Name : TOBI PODHALER

Patent Number : 2570976

Filing Date : 2005-06-20

Strength per Unit : 28 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral Inhalation

Patent Expiration Date : 2025-06-20

Date Granted : 2013-08-13

blank

03

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Tobramycin

Brand Name : TOBI PODHALER

Patent Number : 2468958

Filing Date : 2002-12-19

Strength per Unit : 28 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral Inhalation

Patent Expiration Date : 2022-12-19

Date Granted : 2012-07-03

blank